Eddie Cliff

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Eddie Cliff
Jun 20, 2025, 16:48 | Science
Eddie Cliff: COALITION Study Compares Results of Glofitamab Combinations in LBCL
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about…
Jun 20, 2025, 11:29 | Blog
Eddie Cliff: BC Cancer algorithm for treatment of newly-diagnosed DLBCL based on recent Canadian recommendation
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X: "David…
Jun 17, 2025, 08:32 | Blog
Eddie Cliff: New Lancet Haematology Podcast Featuring a Discussion of our Commission on Adverse Events in Haematology
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, posted on X: "Listening for the…
Jun 14, 2025, 06:58 | Blog
Eddie Cliff Shares Insights from The Lancet Haematology Commission on Improving Adverse Event Measurement
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, posted on X: "Great to join…
Jan 9, 2025, 13:12 | Insight
Jason Liebowitz: Doctors thought they knew what a genetic disease is - they were wrong
Jason Liebowitz, Assistant Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons,…
Dec 13, 2024, 15:39 | Societies
Best of 66th ASH Annual Meeting and Exposition
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 11, 2024, 19:11 | Drugs
Results of AQUILA Trial: Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Daratumumab, an anti-CD38 monoclonal antibody, has been approved for treating multiple myeloma. On December 9th…
Dec 10, 2024, 13:56 | Blog
Eddie Cliff: Headline results of updated TRIANGLE study
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, posted the following on X: “ASCT is…
Dec 8, 2024, 06:11 | Societies
Highlights from Day 1 of ASH 2024 Annual Meeting and Exposition
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition is being held from…
Oct 19, 2024, 16:40 | Blog
Nico Gagelmann: Honored to Receive ASH Abstract Achievement Award
Nico Gagelmann, Co-founder and co-chair the European Society for Blood and Marrow Transplantation (EBMT) Trainee…
Aug 19, 2024, 10:29 | Insight
New ELN classification of AML receiving less intense therapies
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about…
Jul 28, 2024, 15:35 | Blog
Eddie Cliff: Fantastic illustrated review of the evidence supporting DOACs in VTE
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared on X: "Fantastic and very…
Jul 9, 2024, 06:46 | Blog
David Cordas dos Santos: Nonrelapse mortality after CAR-T cell treatment
David Cordas dos Santos, PostDoc at Dana-Farber Cancer Institute, made the following post on X:…
Jul 8, 2024, 17:31 | Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
Jun 26, 2024, 15:14 | Blog
Updated 2023 impact factor list for hematology/oncology journals
Eddie Cliff, Postdoctoral Research Fellow at Harvard Medical School, shared a post on X:  .…
Jun 12, 2024, 05:15 | Blog
Brand new episode on updates in Myeloma MRD - Blood Cancer Talks
Ben Derman, Assistant Professor at the University of Chicago, recently shared a post by Blood…
Apr 14, 2024, 15:19 | Blog
Eddie Cliff: Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs
Eddie Cliff, Postdoctoral Research Fellow at Harvard Medical School, shared a post on X: "Delighted to present…
Mar 26, 2024, 09:53 | Blog
Manni Mohyuddin: Dr. Tefferi's advice is so REFRESHING and AUTHENTIC
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, recently posted on…
Nov 14, 2023, 04:36 | Blog
Manni Mohyuddin: We analyze use of terms that minimize toxicity in myeloma trials
Manni Mohyuddin, Assistant Professor, Huntsman Cancer Institute, University of Utah, shared a post on X/Twitter:…
All: 19 Posts: 1 - 100
Special Coverage